Navigation Links
Physician's Drug Handbook, 10th Ed

ProductsPhysician's Drug Handbook, 10th Ed
Company Skyscape, Inc.
Item Physician's Drug Handbook, 10th Ed
Features 
  • Each entry includes US and Canadian generic and trade names, pharmacologic and therapeutic classifications, pregnancy risk category, controlled substance schedule (when appropriate), available forms and strengths, indications and dosages, pharmacodynamics, pharmacokinetics, contraindications and precautions, interactions (with drugs, foods, herbs, and lifestyle choices), adverse reactions classified five ways, effects on lab test results, overdose and treatment, special considerations, and subsections for pregnant, breast-feeding, pediatric, and geriatric patients
  • A patient teaching section is also included
  • This 10th edition is thoroughly updated with dozens of new FDA approvals and new indications and an updated appendix on herbal medicines
  • Other appendices include guidelines for use of selected antimicrobials, selected analgesic combination products, topical drugs, cytochrome P-450 enzymes and common drug interactions, therapeutic drug monitoring, dialyzable drugs, and phone numbers and Web addresses for pharmaceutical companies, agencies, and organizations
Description Alphabetically organized monographs on more than 1,000 generic and 3,000 trade name drugs.
Info Skyscape, Inc.
Customer Service: 508-460-6500
Web site: http://www.skyscape.com/index/home.aspx

Related medicine products :

1. 5107 Bariatric Physicians Scale®
2. Nursing I.V. Drug Handbook, 8th Ed.
3. The M.D. Anderson Surgical Oncology Handbook, 3rd Ed.
NIVEA body Good-bye Cellulite Gel-Cream visibly reduces the appearance of cellulite.
Safe-Wrap tubes are heparinized glass capillary devices wrapped in a puncture-resistant film. These tubes are used for the collection of capillary blood samples for the measurement of pH, blood gases
...le off white, moist, tough but flexible flat sheet... elastin fibres presented moist in sterile saline....ouble vacuum packed aluminium foil/polyethylene sa...ilised by gamma irradiation. Porcine dermal collag...
Safe-Wrap Combo Blood Collection Tubes are used for the collection of capillary blood samples for use with i-STAT blood gas, electrolyte, and chemistry cartridges requiring either 95 L or 65 L of sam
Medicine Products:
(Date:8/20/2008)...n, adult females, but not in men, study finds , ...lcoholism is associated with delayed childbearing ...,s and men,s lifetime history of alcohol dependenc..., The researchers analyzed data from two groups... female and 1,880 male twins) and between 1964-19...
(Date:8/20/2008)...e/ -- WXYZ- TV/Channel 7 and The,Detroit Departmen...ands of,Detroit metro area children a "boost" at t...This year the program will be held Sunday, August ...Wright Museum of African,American History. Since i...s provided free immunizations to over 50,000 young...
(Date:8/20/2008)...swire-FirstCall/ -- Tianyin,Pharmaceutical, Co., I...rer,and supplier of modernized traditional Chinese...nnounced that the Company,s stock symbol had been,...electronic eligibility,system error., The error i...cts the,stock symbol to trade under the symbol OTC...
(Date:8/20/2008)...urteen physicians who have been,part of Commonweal...enhance,the care and service they provide to their...are top-notch primary care physicians, and we are ...on," said Nick Turkal, M.D., Aurora,s,president an...king with,them to support their care of patients i...
Breaking Medicine News(10 mins):Health News:Women's Alcohol Use Tied to Delayed Childbearing 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3Health News:Tianyin Pharmaceutical Co., Inc. Announces Trading Symbol Error and Correction 2Health News:Commonwealth Medical Group Physicians to Join Aurora Health Care 2
...ho have implanted devices in their hearts face ris...ake arteries patent or open to allow an easy passa...s by surgeons.Stents may be medicated or non medic...o suffer from internal blood clotting. The risk is...
...keenly studied the effect of discontinuing HIV dru...red. The results can be positively// devastating, ...e has published the results of this current resear...ntinued, the patients face a greater chance of dev...
...s that are used in treatment of cancer, are likely...y a research, published by the Journal of Biology.... in brain damage. The effects may be long lasting....enon termed 'chemobrain'.Chemobrain refers to the ...
...e to consume junk food which is over laden with sa...f traditional home made food. This has resulted in...er concentration of salt as their salt receptors a...s like childhood hypertension and early developmen...
Other Medicine News:Health News:Using Heart Stents Tends to Form More Clots 2Health News:Interrupted Treatment Dangerous to HIV Management 2
(Date:8/18/2008)...ndings offer hope for increased life expectancy fo.../PRNewswire-USNewswire/ -- In the world of Down,sy...rogress has been,tracked for the past 16 years, at...ife expectancy of a person with Down syndrome, cur...,Mr. C, was born. Further, ,Mr. C, does,not exhibi...
(Date:8/18/2008)...Leader with Strong Clinical Research Relationships...nizations to Lead Commercialization, SANTA CLARA,...io, Inc.,(OTC Bulletin Board: NWCI) a cardiac dia... Vincent W. Renz has joined NewCardio as its presi...alization effort, to include,business development,...
(Date:8/17/2008)...Australia, Aug. 17 /Xinhua-...ed that the first pivotal Phase 3,clinical trial o...has,completed enrolment., The first efficacy data... the first half of 2009. The trial commenced its d...ruitment target of 250 subjects in June,2008 and c...
(Date:8/14/2008)... A Complimentary Continuing Education Activity, ...ovirus (CMV) is a,significant cause of morbidity a...ell transplantation. The clinical manifestations o...estinal disease to life-threatening,pneumonia, mye...rder to prevent CMV infection and reduce CMV drug ...
Breaking Medicine Technology:Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3Vincent W. Renz Joins NewCardio as President 2Vincent W. Renz Joins NewCardio as President 3Vincent W. Renz Joins NewCardio as President 4Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance 2Study Suggests Risperidone Long Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 2962 1Study Suggests Risperidone Long Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 2962 2Study Suggests Risperidone Long Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 2962 3Study Suggests Risperidone Long Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 2962 4Study Suggests Risperidone Long Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 2962 5HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora Ontario Wal Mart Store 23 5778 10831 1HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora Ontario Wal Mart Store 23 5778 10831 2HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora Ontario Wal Mart Store 23 5778 10831 3HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora Ontario Wal Mart Store 23 5778 10831 4IDM Pharma Announces Phase 3 Mifamurtide 28L MTP PE 29 Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 1304 1IDM Pharma Announces Phase 3 Mifamurtide 28L MTP PE 29 Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 1304 2IDM Pharma Announces Phase 3 Mifamurtide 28L MTP PE 29 Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 1304 3IDM Pharma Announces Phase 3 Mifamurtide 28L MTP PE 29 Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 1304 4IDM Pharma Announces Phase 3 Mifamurtide 28L MTP PE 29 Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 1304 5IDM Pharma Announces Phase 3 Mifamurtide 28L MTP PE 29 Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 1304 6IDM Pharma Announces Phase 3 Mifamurtide 28L MTP PE 29 Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 1304 7Biopure Launches Updated Website 2955 1Biopure Launches Updated Website 2955 2
...gium, March 28, 2007,/PRNewswire-FirstCall/ -- Bio...lts of a sample collection study aimed at,identify...n the,assessment for risk of sepsis progression. S...rapeutic options. Clinical investigator,Emanuel P...,research at the department of emergency medicine ...
...e World,s First Commercial Vaccine,for Travellers,...mpletes Phase I Clinical Trials , ,Trial confirms ...ENSE, Denmark, March 28, 2007 -ACE BioSciences A/S...nounce the successful,completion of Phase I clinic...,s first commercial vaccine for Travellers,Diarrh...
Other Medicine Technology:Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 2Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 3Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 4Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 5Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 2Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 3Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 4